OTC Anthrax MedKit Development Relies On Incremental Approach

05 Mar 2012

• By Dan Schiff

HHS’ Biomedical Advanced Research and Development Authority will ask FDA and its advisors about the feasibility of an OTC antibiotic MedKit for anthrax treatment at an advisory committee meeting.

The Department of Health and Human Services will take another crack at allowing home stockpiling of a MedKit, scheduling a joint FDA advisory committee meeting to discuss OTC use of the antibiotic doxycycline hyclate to treat anthrax.

While HHS’ Biomedical Advanced Research and Development Authority failed in its 2008 proposal for home use of an antiviral MedKit...